Antiphospholipid syndrome in patients with venous thromboembolism
Unprovoked (or provoked by mild risk factors) venous thromboembolism (VTE) in young
patients, VTE in uncommon sites, or cases of unexplained VTE recurrence may be positive …
patients, VTE in uncommon sites, or cases of unexplained VTE recurrence may be positive …
A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance
T Foret, V Dufrost, L Salomon du Mont, P Costa… - …, 2022 - academic.oup.com
Objectives In APS, precise evaluation of thrombotic risk is a major challenge. Different
players, such as activated protein C (APC) resistance or neutrophil extracellular traps …
players, such as activated protein C (APC) resistance or neutrophil extracellular traps …
Antiphospholipid syndrome-related pulmonary embolism: clinical characteristics and early recognition
M Shi, W Gao, Y Jin, J Zhu, Y Liu, T Wang… - Frontiers in …, 2022 - frontiersin.org
Background Pulmonary thromboembolism is a common disease frequently encountered in
the emergency room and has a high mortality rate. Antiphospholipid syndrome (APS) is a …
the emergency room and has a high mortality rate. Antiphospholipid syndrome (APS) is a …
Neurovascular Manifestations of Iron-Deficient Anemia: Narrative Review and Practical Reflections through a Teaching Case
M Zedde, G Portaro, L Ferri, F Cavallieri… - Journal of Clinical …, 2022 - mdpi.com
Anemia is one of the most frequent diseases worldwide, affecting one-third of the general
population. Anemia in general and in particular, iron-deficient anemia (IDA), has been …
population. Anemia in general and in particular, iron-deficient anemia (IDA), has been …
Apixaban versus vitamin K antagonists in patients with antiphospholipid syndrome: a cohort study
M Sikorska, J Chmiel, E Papuga-Szela… - Journal of …, 2022 - journals.lww.com
Current guidelines recommend that direct anticoagulants should not be used in prevention
of recurrent thrombosis in patients with antiphospholipid syndrome (APS). However, except …
of recurrent thrombosis in patients with antiphospholipid syndrome (APS). However, except …
Coagulation diagnostics in the clinical routine-part 2: Monitoring of anticoagulation treatment, new-onset thrombocytopenia and thrombophilia
M Metze, M Platz, C Pfrepper… - Innere Medizin (Heidelberg …, 2022 - europepmc.org
Während bei einer Vitamin-K-Antagonisten-Therapie die Therapieüberwachung
(International Normalized Ratio [INR]) obligat ist, gilt dies für direkte orale Antikoagulanzien …
(International Normalized Ratio [INR]) obligat ist, gilt dies für direkte orale Antikoagulanzien …
Duration of Anticoagulant Therapy for Unprovoked Venous Thromboembolism
F Khan - 2022 - ruor.uottawa.ca
Venous thromboembolism (VTE) is a chronic illness that affects nearly 10 million people
every year worldwide. Anticoagulant therapy with direct oral anticoagulants is the mainstay …
every year worldwide. Anticoagulant therapy with direct oral anticoagulants is the mainstay …
Gerinnungsdiagnostik im klinischen Alltag–Teil 2
M Metze, M Platz, C Pfrepper, S Petros - Die Innere Medizin, 2022 - Springer
Während bei einer Vitamin-K-Antagonisten-Therapie die Therapieüberwachung
(International Normalized Ratio [INR]) obligat ist, gilt dies für direkte orale Antikoagulanzien …
(International Normalized Ratio [INR]) obligat ist, gilt dies für direkte orale Antikoagulanzien …
[PDF][PDF] Syndrome des anticorps anti-phospholipides: critères diagnostiques et conduite à tenir pratique au laboratoire
M Samouche, MB Moumni, H Elasri… - Journal of Medical and …, 2022 - academia.edu
Le syndrome des antiphospholipides (SAPL) est une maladie auto-immune systémique
caractérisée par un état d'hypercoagulabilité secondaire à la présence d'auto-anticorps …
caractérisée par un état d'hypercoagulabilité secondaire à la présence d'auto-anticorps …